Loading...
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
BACKGROUND/AIMS: The success of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) has focused interest on the role of Ras signaling in this malignancy. We investigated the molecular alterations of the Ras pathway in HCC and the antineoplastic effects of sorafenib in combination w...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2009
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2970800/ https://ncbi.nlm.nih.gov/pubmed/19665249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2009.03.028 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|